A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells

This publication has 27 references indexed in Scilit:

• Efficacy of Low‐Dose Intermittent Subcutaneous Interleukin (IL)–2 in Antiviral Drug–Experienced Human Immunodeficiency Virus–Infected Persons with Detectable Virus Load: A Controlled Study of 3 IL‐2 Regimens with Antiviral Drug Therapy
  The Journal of Infectious Diseases, 2001
• The impact of highly active antiretroviral therapy on HIV-specific immune function
  AIDS, 2001
• A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand
  AIDS, 2000
• A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4⁺Cell Counts ⩾350/mm³
  The Journal of Infectious Diseases, 2000
• Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial
  The Lancet, 1999
• A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection
  The Journal of Infectious Diseases, 1999
• Outpatient Continuous Intravenous Interleukin‐2 or Subcutaneous, Polyethylene Glycol‐Modified Interleukin‐2 in Human Immunodeficiency Virus‐Infected Patients: A Randomized, Controlled, Multicenter Study
  The Journal of Infectious Diseases, 1998
• Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons
  The Journal of Infectious Diseases, 1997
• Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus
  New England Journal of Medicine, 1996
• Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study
  New England Journal of Medicine, 1995